LGALS3BP and COVID-19: Interestingly, we identified low to absent LGALS3BP expression levels in CD163hi and HLA-DRlo S100Ahi monocytes of cohort A in severe COVID-19 (Fig. 4A) while patients with mild COVID-19 showed elevated levels compared to controls.